Delivery Order SPE2DB24D6041-SPE2DB24FKBHJ

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $9.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $9,454.97 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4562549929 ELIQUIS 5 MG TABLET 60S, a cardiovascular medication, with an ultimate completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a $12,009.97 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of ELIQUIS 5 MG TABLET 60S. The contract has an ultimate completion date of April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a $27,322.31 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 24, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract...
This is a $6,334.92 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ELIQUIS 2.5 MG TABLET 60S. The contract is a firm fixed-price, non-set-aside award with a completion date of June 25, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a $15,299.21 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4568296791 ELIQUIS 5 MG TABLET 60S, with a completion date of May 20, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a comprehensive global pharmaceutical support vehicle through December...
This is a $14,627.31 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for 4564390404 ELIQUIS 5 MG TABLET 60S, a cardiovascular medication. The ultimate completion date is April 25, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a range of pharmaceutical products...
This is a $11,291.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a medication, and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a $22,381.70 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565564679 ELIQUIS 5 MG TABLET 60S. The contract has an ultimate completion date of August 26, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000...
This is a $21,795.60 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a common prescription medication. The order has an ultimate completion date of August 15, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a range...
The U.S. Defense Logistics Agency (DLA) awarded a $7,807.53 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4565767348 ELIQUIS 5 MG TABLET 60S. This order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
  • SPE2DB24D6041
    Indefinite Delivery Contract
  • SPE2DB24D6041-SPE2DB24FKBHJ
    Delivery Order

This is a $9,320.04 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565288874 ELIQUIS 5 MG TABLET 60S. The contract has a completion date of July 31, 2024 and is a firm fixed-price arrangement. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as well as multiple indefinite delivery contracts (IDCs) with the DLA and Department of Justice for the provision of a wide range of essential medical commodities, including specialty medications, vaccines, and medical supplies, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. This contract award does not utilize a set-aside designation.

Generated 10/29/24, 9:19 AM